Levi & Korsinsky Investigates GRAIL, Inc. (GRAL) Over Possible Securities Fraud

Group 1 - The investigation into GRAIL, Inc. by Levi & Korsinsky focuses on potential violations of federal securities laws [1] - GRAIL, Inc. updated its cash-burn guidance to no more than $290 million for the full year of 2025, indicating a significant financial outlook [2] - The company believes its cash runway extends into 2030, which is expected to support major clinical and regulatory milestones, including the FDA PMA submission and results from the NHS Galleri study [2] Group 2 - Levi & Korsinsky has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4] - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]